Nutriband Inc (NTRB): Kewajiban utang agregat

Pain therapy safety requires new standards, making the development of the Nutriband Inc. (NTRB) transdermal delivery system critically important. The total liabilities metric demonstrates financial dynamics, where the current level equals 0.00. Capitalization growth relies on the upcoming FDA approval of the Aversa patch and global licenses. Diversified suppliers and established inventory reserves guarantee business stability.

Nutriband Inc. (NTRB) development of innovative transdermal drug delivery systems requires significant capital, which is reflected in the current debt status on the GURU.Markets platform. This indicator compares the total volume of borrowed obligations with the issuer's market capitalization, allowing investors to assess the real debt load on the business and the extent to which the financing of expansion in the pharmaceutical sector depends on external credit resources.